Evidence map›Paper›PMID 37738167›Full record

ArticleBlood advances2023

Complementary HLH susceptibility factors converge on CD8 T-cell hyperactivation.

Emily Landy, Jemy Varghese, Vinh Dang, Andrea Szymczak-Workman, Lawrence P Kane, Scott W Canna

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Role of DOCK8 in cytokine storm syndromes.The Journal of allergy and clinical immunology · 2025
    Article
  7. Weal and woe of interleukin-18 in the T cell therapy of cancer.Journal for immunotherapy of cancer · 2025
    Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Emily LandyDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0002-7635-7781
Jemy VargheseRheumatology & Immune Dysregulation, Children's Hospital of Philadelphia, Philadelphia, PA.
Vinh DangRheumatology & Immune Dysregulation, Children's Hospital of Philadelphia, Philadelphia, PA.ORCID 0000-0002-5396-2532
Andrea Szymczak-WorkmanDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA.
Lawrence P KaneDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0001-5198-516X
Scott W CannaRheumatology & Immune Dysregulation, Children's Hospital of Philadelphia, Philadelphia, PA.ORCID 0000-0003-3837-5337
Children's Hospital of Philadelphia · USUniversity of Pittsburgh · US

Funding

Understanding Interleukin-18 Mediated Susceptibility to Systemic HyperinflammationR01HD098428 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CANNA, SCOTT WILLIAM · 2019 to 2023
$1.7M
NICHD NIH HHS R01 HD098428
6 · The paper itself

Abstract

Hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS) are life-threatening hyperinflammatory syndromes. Familial HLH is caused by genetic impairment of granule-mediated cytotoxicity (eg, perforin deficiency). MAS is linked to excess activity of the inflammasome-activated cytokine interleukin-18 (IL-18). Though individually tolerated, mice with dual susceptibility (Prf1⁻/⁻Il18tg; DS) succumb to spontaneous, lethal hyperinflammation. We hypothesized that understanding how these susceptibility factors synergize would uncover key pathomechanisms in the activation, function, and persistence of hyperactivated CD8 T cells. In IL-18 transgenic (Il18tg) mice, IL-18 effects on CD8 T cells drove MAS after a viral (lymphocytic choriomeningitis virus), but not innate (toll like receptor 9), trigger. In vitro, CD8 T cells also required T-cell receptor (TCR) stimulation to fully respond to IL-18. IL-18 induced but perforin deficiency impaired immunoregulatory restimulation-induced cell death (RICD). Paralleling hyperinflammation, DS mice displayed massive postthymic oligoclonal CD8 T-cell hyperactivation in their spleens, livers, and bone marrow as early as 3 weeks. These cells increased proliferation and interferon gamma production, which contrasted with increased expression of receptors and transcription factors associated with exhaustion. Broad-spectrum antibiotics and antiretrovirals failed to ameliorate the disease. Attempting to genetically "fix" TCR antigen-specificity instead demonstrated the persistence of spontaneous HLH and hyperactivation, chiefly on T cells that had evaded TCR fixation. Thus, drivers of HLH may preferentially act on CD8 T cells: IL-18 amplifies activation and demand for RICD, whereas perforin supplies critical immunoregulation. Together, these factors promote a terminal CD8 T-cell activation state, combining features of exhaustion and effector function. Therefore, susceptibility to hyperinflammation may converge on a unique, unrelenting, and antigen-dependent state of CD8 T-cell hyperactivation.

Indexed as

Lymphohistiocytosis, HemophagocyticAnimalsCD8-Positive T-LymphocytesInterleukin-18MicePerforinReceptors, Antigen, T-CellInterleukin-18PerforinReceptors, Antigen, T-Cell

Identifiers

PMID37738167
PMCPMC10690564
OpenAlexW4386954832

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.